Reevaluating the benefits of folic acid fortification in the United States: economic analysis, regulation, and public health
- PMID: 16195513
- PMCID: PMC1449459
- DOI: 10.2105/AJPH.2004.058859
Reevaluating the benefits of folic acid fortification in the United States: economic analysis, regulation, and public health
Abstract
Before a 1996 US regulation requiring fortification of enriched cereal-grain products with folic acid, 3 economic evaluations projected net economic benefits or cost savings of folic acid fortification resulting from the prevention of pregnancies affected by a neural tube defect. Because the observed decline in neural tube defect rates is greater than was forecast before fortification, the economic gains are correspondingly larger. Applying both cost-benefit and cost-effectiveness analytic techniques, we estimated that folic acid fortification is associated with annual economic benefit of 312 million dollars to 425 million dollars. The cost savings (net reduction in direct costs) were estimated to be in the range of 88 million dollars to 145 million dollars per year.
Similar articles
-
A cost-effectiveness analysis of folic acid fortification policy in the United States.Public Health Nutr. 2009 Apr;12(4):455-67. doi: 10.1017/S1368980008002565. Epub 2008 Jul 1. Public Health Nutr. 2009. PMID: 18590584 Free PMC article.
-
Folic acid fortification of grain: an economic analysis.Am J Public Health. 1995 May;85(5):667-76. doi: 10.2105/ajph.85.5.667. Am J Public Health. 1995. PMID: 7733427 Free PMC article.
-
Economic evaluation of folic acid food fortification in The Netherlands.Eur J Public Health. 2008 Jun;18(3):270-4. doi: 10.1093/eurpub/ckm129. Epub 2008 Jan 31. Eur J Public Health. 2008. PMID: 18238826
-
Economic burden of neural tube defects and impact of prevention with folic acid: a literature review.Eur J Pediatr. 2011 Nov;170(11):1391-400. doi: 10.1007/s00431-011-1492-8. Epub 2011 May 19. Eur J Pediatr. 2011. PMID: 21594574 Free PMC article. Review.
-
Folate fortification for the prevention of birth defects: case study.Am J Epidemiol. 2001 Dec 15;154(12 Suppl):S60-9. doi: 10.1093/aje/154.12.s60. Am J Epidemiol. 2001. PMID: 11744531 Review. No abstract available.
Cited by
-
Using an experiment among clinical experts to determine the cost and clinical impact of rapid whole exome sequencing in acute pediatric settings.Front Pediatr. 2023 Jul 3;11:1204853. doi: 10.3389/fped.2023.1204853. eCollection 2023. Front Pediatr. 2023. PMID: 37465423 Free PMC article.
-
Folic Acid and the Prevention of Birth Defects: 30 Years of Opportunity and Controversies.Annu Rev Nutr. 2022 Aug 22;42:423-452. doi: 10.1146/annurev-nutr-043020-091647. Annu Rev Nutr. 2022. PMID: 35995050 Free PMC article. Review.
-
Cost-effectiveness of mandatory folic acid fortification of flours in prevention of neural tube defects: A systematic review.PLoS One. 2021 Oct 21;16(10):e0258488. doi: 10.1371/journal.pone.0258488. eCollection 2021. PLoS One. 2021. PMID: 34673787 Free PMC article.
-
Data Needs for Economic Evaluations of Screening in Pediatric Primary Care: A Research Framework.Pediatrics. 2021 Jul;148(Suppl 1):s45-s50. doi: 10.1542/peds.2021-050693J. Pediatrics. 2021. PMID: 34210848 Free PMC article. Review. No abstract available.
-
Monetary Valuation of Children's Cognitive Outcomes in Economic Evaluations from a Societal Perspective: A Review.Children (Basel). 2021 Apr 29;8(5):352. doi: 10.3390/children8050352. Children (Basel). 2021. PMID: 33946651 Free PMC article. Review.
References
-
- US Food and Drug Administration. Food standards: amendments of standards of identity for enriched grain products to require addition of folic acid. Federal Register. 1996;61:8781–8797.
-
- Feinleib M, Beresford SA, Bowman BA, et al. Folate fortification for the prevention of birth defects: case study. Am J Epidemiol. 2001;154:S60–S69. - PubMed
-
- US Food and Drug Administration. Food standards: amendment of the standards of identity for enriched grain products to require addition of folic acid. Federal Register. 1993;58:53305–53312.
-
- Kelly AE, Haddix AC, Scanlon KS, Helmick CG, Mulinare J. Cost-effectiveness of strategies to prevent neural tube defects. In: Gold MR, Siegel JE, Russell LB, Weinstein MC, eds. Cost-Effectiveness in Health and Medicine. New York, NY: Oxford University Press; 1996:312–349.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical